Baron Discovery Fund reports Q4 2025 performance and details new positions in Waystar Holding and Casella Waste Systems. Read ...

Series 1 is a massive set with a lot to offer, but figuring out the best configuration to buy can be hard. We're here to help ...

Enter Micron Technology ( MU +0.89%). With shares up 317% over the last 12 months, the memory giant is quickly following in ...

PolyPid Ltd. (NASDAQ:PYPD) Q4 2025 Earnings Call Transcript February 11, 2026 PolyPid Ltd. misses on earnings expectations.

If you’re a CX leader, you need to make sure your organization’s North Star is constructed in a way that teams can actually use. When it’s defined and applied effectively, it unites stakeholders ...

Discusses Recent Financing and Strategy to Buy Back Gold Hedge Contracts February 12, 2026 3:00 PM ESTCompany ParticipantsRick ...

Europe's smoke-flavor phaseout forces snack makers to rethink recipes, labels and timelines before taste and trust drift so ...

Another popular horse idiom in China is "celestial horse galloping through the sky," which is used to describe thoughts or actions that are unrestrained, without limitations. This year, China's space ...

Enamine's Target-Agnostic Expertise in Biology, Drug Design, and Medicinal Chemistry Advances EMUNO Therapeutics ...

The Garland Fund was not a typical foundation, but its history shows the potential role philanthropy can play in moments of ...

Pharm Exec’s 21st Annual Pipeline Report examines emerging drug development classes, treatment modalities, and expansion pursuits in five therapeutic settings ripe for next-gen innovation.

Pharm Exec’s 21st Annual Pipeline Report examines emerging drug development classes, treatment modalities, and expansion pursuits in five therapeutic settings ripe for next-gen innovation.